Skip to main content

Xeno Biosciences

Somerville, United States

Xeno Biosciences is a biotechnology company that provides novel class of treatments for metabolic diseases.

$1.5M raised
Jan 2023
Debt Financing

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Xeno Biosciences

How much funding has Xeno Biosciences raised?
Xeno Biosciences has raised $1.5M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2023.
Who are Xeno Biosciences's investors?
Xeno Biosciences's investors include Maine Angels, ScOp Venture Capital, Dirigo Angels, Bantam Group, Keiretsu Forum.
Where is Xeno Biosciences headquartered?
Xeno Biosciences is headquartered in Somerville, United States.
What does Xeno Biosciences do?
Xeno Biosciences is a biotechnology company that provides novel class of treatments for metabolic diseases.
What stage is Xeno Biosciences at?
Xeno Biosciences is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Xeno Biosciences — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/xeno-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2023). Xeno Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/xeno-biosciences
Wikipedia (cite web)
{{cite web |title=Xeno Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/xeno-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .